Hesaneh Ahmadi

Hesaneh Ahmadi

Auto-generated profile, based on publicly available information

Hesaneh Ahmadi

Department of Chemical Engineering, Texas Tech University, Lubbock, TX, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2025 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
RJRutwik Joshi
Rutwik Joshi
Raheel AhmadRaheel Ahmad
Raheel Ahmad
KGKarl Gardner
Karl Gardner
HAHesaneh Ahmadi
Hesaneh Ahmadi
CCChau-Chyun Chen
Chau-Chyun Chen
WLWei Li
Wei Li
Biomaterials and machine learning enable isolation, profiling, and clinical translation of circulating tumor cells and extracellular vesicles to address tumor heterogeneity and therapy resistance.

10 January 2025 in Materials Today Bio
Verified
Journal Article
Open access
RJRutwik Joshi
Rutwik Joshi
HAHesaneh Ahmadi
Hesaneh Ahmadi
MKMd Nayeem Hasan Kashem
Md Nayeem Hasan Kashem
FAFariha Afnan
Fariha Afnan
SPSiva Parameswaran
Siva Parameswaran
WLWei Li
Wei Li
Timely isolation, recovery, and identification of Salmonella from food samples is essential for prevention and control of foodborne Salmonella outbreaks. Traditional culture-based Salmonella isolation and serotyping techniques are time consuming and labor intensive. Despite the progress of innovative microfluidic or immunomagnetic isolation techniques, sophisticated lab equipment and microfabrication are often needed. Here, we present a novel, rapid yet simple method for isolation and recovery of Salmonella from mixed bacterial populations in food matrices and blood. This method utilizes self-floating hollow glass microspheres (HGMS) coated with biodegradable layer-by-layer (LbL) films and Salmonella specific antibodies. The isolation and recovery process can be completed in less than 2 h, without any sophisticated laboratory equipment or external force. In this study, we demonstrate that Salmonella can be captured due to antigen-antibody interactions on the surface of HGMS, allowing them to float to the top. The HGMS can then be washed and subjected to enzymatic degradation of the LbL film to recover the captured bacteria. The recovered Salmonella can subsequently be grown on selective agar plates for further analysis. Recovery efficiency of up to 22 % and detection limit of 100 CFU/mL were achieved. This method is expected to provide a viable alternative to traditional isolation techniques, especially in resource limited areas.

5 October 2026 in Journal of Polymer Science
Verified
Journal Article
Open access
PDF file
HAHesaneh Ahmadi
Hesaneh Ahmadi
NFNur Hendri Wahyu Firdaus
Nur Hendri Wahyu Firdaus
RJRutwik Joshi
Rutwik Joshi
ASAkhilesh Kumar Shakya
Akhilesh Kumar Shakya
WLWei Li
Wei Li
Peanut allergy can lead to severe and life‐threatening reactions, yet management still relies primarily on strict peanut avoidance. Because IgE antibodies play a critical role in driving allergic responses, several therapeutic strategies target the IgE pathway. However, these approaches often require biologics and can be limited by cost, dosing constraints, or systemic side effects. Here, we present a microfluidic immunoadsorption platform functionalized with a layer‐by‐layer (LbL) assembly of poly(diallyldimethylammonium chloride) (PDDA) and peanut allergens nanofilms to selectively capture peanut‐specific antibodies directly from the whole blood of peanut allergy mouse. The LbL coating formed a uniform surface in microfluidic channels as confirmed by fluorescence microscopy, SEM, and QCM‐D assessments. Using serum from peanut‐sensitized mice, the peanut protein extract (PE) coated device demonstrated efficient depletion of anti‐PE IgG. When operated with unprocessed whole blood, the device achieved measurable removal of PE‐specific antibodies in continuous flow conditions without significant hemolysis, altering red blood cell count, mast cell activation, or oxidative stress. These results demonstrate that PE functionalized LbL microfluidic immunoadsorption enables selective antibody depletion using minimal blood volumes and without preprocessing, offering a low shear and biocompatible alternative to conventional extracorporeal systems.